Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Empagliflozin”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT03208465
What this trial is testing

Empagliflozin Versus Sitagliptin Therapy for Improvement of Myocardial Perfusion Reserve in Diabetic Patients With Coronary Artery Disease

Who this might be right for
Diabetes MellitusCoronary Disease
CHEOL WHAN LEE, M.D., Ph.D 100
Not applicableStudy completedNCT02848833
What this trial is testing

JARDIANCE Regulartory Post Marketing Surveillance in Korean Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 3,368
Not applicableStudy completedNCT05465317
What this trial is testing

Evaluating Comparative Effectiveness of Empagliflozin in Type 2 Diabetes Population With and Without Chronic Kidney Disease

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 62,197
Early research (Phase 1)Looking for participantsNCT07331389
What this trial is testing

A Drug-Drug Interaction Study of HDM1002 and Metformin, Empagliflozin, Midazolam, Valsartan, and Warfarin

Who this might be right for
Overweight SubjectHealthy Subjects
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. 111
Testing effectiveness (Phase 2)Study completedNCT01011868
What this trial is testing

Efficacy and Safety of BI 10773 in Combination With Insulin in Patients With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 494
Not applicableStudy completedNCT05229796
What this trial is testing

Pharmacokinetics and Bioequivalence of Two Empagliflozin, With Evaluation in Healthy Jordanian Subjects Under Fasting and Fed Conditions

Who this might be right for
Pharmacokinetic Parameters
Mutah University 26
Early research (Phase 1)Study completedNCT02172235
What this trial is testing

Relative Bioavailability of Pioglitazone After Co-administration With Different Doses of BI 10773 in Healthy Volunteers

Who this might be right for
Healthy
Boehringer Ingelheim 20
Early research (Phase 1)Study completedNCT03629054
What this trial is testing

This Study in Healthy People Tests Whether Taking a Low Strength of Empagliflozin, Linagliptin, and Metformin Together in 1 Pill is the Same as Taking Them in Separate Pills

Who this might be right for
Healthy
Boehringer Ingelheim 30
Post-approval studies (Phase 4)Looking for participantsNCT07074418
What this trial is testing

Effect of Empagliflozin in Patients With eGFR Between 10 and 20 ml/Min/1.73m2

Who this might be right for
Chronic Kidney Diseases
Centre Hospitalier Universitaire de Nice 34
Large-scale testing (Phase 3)Study completedNCT03087773
What this trial is testing

Impact of EMpagliflozin on Cardiac Function and Biomarkers of Heart Failure in Patients With Acute MYocardial Infarction

Who this might be right for
Acute Myocardial Infarction
Medical University of Graz 476
Testing effectiveness (Phase 2)UnknownNCT06012266
What this trial is testing

Repurposing Empagliflozin and Dapagliflozin for Paediatric Heart Failure: Translational Approach and Dose Rationale

Who this might be right for
Heart Failure
Centre Hospitalier Universitaire Vaudois 12
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07749014
What this trial is testing

Timing of Empagliflozin in Primary PCI: Pre-Reperfusion Versus Post-Reperfusion Versus Placebo in South Asian STEMI Patients

Who this might be right for
ST-elevation Myocardial Infarction (STEMI)Acute Myocardial Infarction (AMI)Coronary Artery Disease
Rehman Medical Institute - RMI 480
Testing effectiveness (Phase 2)Study completedNCT05081219
What this trial is testing

SNIFF - Combo INI+EMPA Trial

Who this might be right for
Mild Cognitive ImpairmentCognitive ImpairmentAlzheimer Disease
Wake Forest University Health Sciences 47
Large-scale testing (Phase 3)Looking for participantsNCT07038356
What this trial is testing

Effects of Continued Administration of Empagliflozin in Patients With Heart Failure on Active SGLT2 Inhibitor Treatment Admitted for Acute Decompensated Heart Failure

Who this might be right for
Acute Decompensated Heart Failure (ADHF)
Christian Schulze 536
Large-scale testing (Phase 3)Study completedNCT01368081
What this trial is testing

Empagliflozin (BI 10773) Comprehensive add-on Study in Japanese Subjects With Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 1,162
Not applicableStudy completedNCT07633028
What this trial is testing

Clinical Study to Determine Bioequivalence Between Two Oral Medications of Empagliflozin/Metformin in 12.5 mg / 850 mg Tablets Under Fed Conditions.

Who this might be right for
Bioequivalence Study in Healthy Subjects
ADIUM 42
Large-scale testing (Phase 3)UnknownNCT01257334
What this trial is testing

Patients With Type 2 Diabetes Mellitus With Insufficient Glycaemic Control Despite Treatment With Metformin Alone or Metformin in Combination With a Sulfonylurea

Who this might be right for
Type 2 Diabetes
Taipei Medical University WanFang Hospital 1,390
Not applicableStudy completedNCT07269197
What this trial is testing

Association of SGLT2 Inhibitors Therapy With Elastographic and Molecular Markers of Liver Injury in Type 2 Diabetes

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseDiabetes Mellitus, Type 2
Josip Juraj Strossmayer University of Osijek 67
Not applicableLooking for participantsNCT07231939
What this trial is testing

Use of Flozins (Empagliflozin/Dapagliflozin) for Prevention of AKI

Who this might be right for
Coronary Artery DiseaseAcute Kidney InjuryContrast-Induced Acute Kidney Injury+1 more
Collegium Medicum w Bydgoszczy 4,000
Large-scale testing (Phase 3)Study completedNCT04342819
What this trial is testing

The Effect of empagliFlozin on Platelet Function profilEs in diabetiC patienTs - The EFFECT Study.

Who this might be right for
Platelet Dysfunction Due to Drugs
The University of The West Indies 25
Next Page